No recent analyst price targets found for KHTRF.
Latest News for KHTRF
Knight Therapeutics Q2 Earnings Call Highlights
Knight Therapeutics TSE: GUD reported record results for the first six months of 2026 and raised its full-year outlook, citing growth in its promoted products, contributions from recent launches and favorable foreign-exchange effects.
Knight Therapeutics Announces Repayment of Revolving Credit Facility
MONTREAL, June 17, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has repaid all amounts outstanding under its revolving credit facility with National Bank of Canada and a syndicate of lenders.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for KHTRF.
Senate Trading
No Senate trades found for KHTRF.
U.S. House Trading
No House trades found for KHTRF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.